News
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...
2d
HealthDay on MSNMenopause Hormone Therapy Boosts GLP-1 Drug Effectiveness, Researchers SayKey Takeaways Menopause hormone therapy appears to boost the effectiveness of tirzepatide (Zepbound)Women lost more weight ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
3d
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersIn 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and postoperative period experienced significantly greater weight loss -- a 33% ...
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results